2016
DOI: 10.1016/j.expneurol.2016.09.002
|View full text |Cite
|
Sign up to set email alerts
|

MHC-I promotes apoptosis of GABAergic interneurons in the spinal dorsal horn and contributes to cancer induced bone pain

Abstract: Cancer induced bone pain (CIBP) remains one of the most intractable clinical problems due to poor understanding of its underlying mechanisms. Recent studies demonstrate the decline of inhibitory interneurons, especially GABAergic interneurons in the spinal cord, can evoke generation of chronic pain. It has also been reported that neuronal MHC-I expression renders neurons vulnerable to cytotoxic CD8 T cells and finally lead to neurons apoptosis in a variety neurological disorders. However, whether MHC-I could i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 57 publications
0
22
0
Order By: Relevance
“…Bone cancer pain (BCP) is one of the most severe type of chronic pain [28][29][30]. It was reported that up to 85% of patients with advanced prostate, breast, and lung cancer had bone metastasis [31][32][33]. Moreover, one-third of these patients experienced unbearable pain, which severely affected their quality of life.…”
Section: Pi3k/akt Pathway and Bone Cancer Painmentioning
confidence: 99%
“…Bone cancer pain (BCP) is one of the most severe type of chronic pain [28][29][30]. It was reported that up to 85% of patients with advanced prostate, breast, and lung cancer had bone metastasis [31][32][33]. Moreover, one-third of these patients experienced unbearable pain, which severely affected their quality of life.…”
Section: Pi3k/akt Pathway and Bone Cancer Painmentioning
confidence: 99%
“…2 μg of total RNA was extracted from mouse spinal cords (C1-C4, C5-C8 or lumbar segment) using TRIzol reagent (Invitrogen, USA) according to the manufacturer’s protocol and quantified using a spectrophotometer (BioPhotometer, Eppendorf, Hamburg, Germany)[ 27 , 46 49 ]. The threshold cycle (CT) was used to estimate the amount of target mRNA.…”
Section: Methodsmentioning
confidence: 99%
“…Among advanced cancer patients 75% suffer from severe pain owing to bone metastasis, which significantly affects their quality of life (Costantini et al, 2009;Zhou et al, 2015;Fu et al, 2016). Currently, the role of CaMKII in bone cancer pain (BCP) remains largely unknown.…”
Section: Camkii and Bone Cancer Painmentioning
confidence: 99%